352 related articles for article (PubMed ID: 30729279)
21. Inhibition of USP7 induces p53-independent tumor growth suppression in triple-negative breast cancers by destabilizing FOXM1.
Yi J; Li H; Chu B; Kon N; Hu X; Hu J; Xiong Y; Kaniskan HU; Jin J; Gu W
Cell Death Differ; 2023 Jul; 30(7):1799-1810. PubMed ID: 37291217
[TBL] [Abstract][Full Text] [Related]
22. Aberrant activation of hedgehog signaling promotes cell proliferation via the transcriptional activation of forkhead Box M1 in colorectal cancer cells.
Wang D; Hu G; Du Y; Zhang C; Lu Q; Lv N; Luo S
J Exp Clin Cancer Res; 2017 Feb; 36(1):23. PubMed ID: 28148279
[TBL] [Abstract][Full Text] [Related]
23. Silencing forkhead box M1 promotes apoptosis and autophagy through SIRT7/mTOR/IGF2 pathway in gastric cancer cells.
Yu W; Cui X; Wan Z; Yu Y; Liu X; Jin L
J Cell Biochem; 2018 Nov; 119(11):9090-9098. PubMed ID: 29953672
[TBL] [Abstract][Full Text] [Related]
24. Gene network analysis using SWIM reveals interplay between the transcription factor-encoding genes HMGA1, FOXM1, and MYBL2 in triple-negative breast cancer.
Fiscon G; Pegoraro S; Conte F; Manfioletti G; Paci P
FEBS Lett; 2021 Jun; 595(11):1569-1586. PubMed ID: 33835503
[TBL] [Abstract][Full Text] [Related]
25. A novel orally available seleno-purine molecule suppresses triple-negative breast cancer cell proliferation and progression to metastasis by inducing cytostatic autophagy.
Chang CH; Bijian K; Wernic D; Su J; da Silva SD; Yu H; Qiu D; Asslan M; Alaoui-Jamali MA
Autophagy; 2019 Aug; 15(8):1376-1390. PubMed ID: 30773992
[TBL] [Abstract][Full Text] [Related]
26. Flubendazole elicits anti-cancer effects via targeting EVA1A-modulated autophagy and apoptosis in Triple-negative Breast Cancer.
Zhen Y; Zhao R; Wang M; Jiang X; Gao F; Fu L; Zhang L; Zhou XL
Theranostics; 2020; 10(18):8080-8097. PubMed ID: 32724459
[No Abstract] [Full Text] [Related]
27. PRRX1/FOXM1 reduces gemcitabin-induced cytotoxicity by regulating autophagy in bladder cancer.
Huang X; Huang W; Wu K; Lin Q; Chen G
Transl Androl Urol; 2022 Aug; 11(8):1116-1129. PubMed ID: 36092834
[TBL] [Abstract][Full Text] [Related]
28. The circRNA circSEPT9 mediated by E2F1 and EIF4A3 facilitates the carcinogenesis and development of triple-negative breast cancer.
Zheng X; Huang M; Xing L; Yang R; Wang X; Jiang R; Zhang L; Chen J
Mol Cancer; 2020 Apr; 19(1):73. PubMed ID: 32264877
[TBL] [Abstract][Full Text] [Related]
29. ANXA2 (annexin A2) is crucial to ATG7-mediated autophagy, leading to tumor aggressiveness in triple-negative breast cancer cells.
Koh M; Lim H; Jin H; Kim M; Hong Y; Hwang YK; Woo Y; Kim ES; Kim SY; Kim KM; Lim HK; Jung J; Kang S; Park B; Lee HB; Han W; Lee MS; Moon A
Autophagy; 2024 Mar; 20(3):659-674. PubMed ID: 38290972
[TBL] [Abstract][Full Text] [Related]
30. Forkhead Box M1 positively regulates UBE2C and protects glioma cells from autophagic death.
Guo L; Ding Z; Huang N; Huang Z; Zhang N; Xia Z
Cell Cycle; 2017 Sep; 16(18):1705-1718. PubMed ID: 28767320
[TBL] [Abstract][Full Text] [Related]
31. High LC3/Beclin Expression Correlates with Poor Survival in Glioma: a Definitive Role for Autophagy as Evidenced by In Vitro Autophagic Flux.
Cj P; Hv E; Vijayakurup V; R Menon G; Nair S; Gopala S
Pathol Oncol Res; 2019 Jan; 25(1):137-148. PubMed ID: 29022195
[TBL] [Abstract][Full Text] [Related]
32. The Anticancer Effects of FDI-6, a FOXM1 Inhibitor, on Triple Negative Breast Cancer.
Ulhaka K; Kanokwiroon K; Khongkow M; Bissanum R; Khunpitak T; Khongkow P
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206484
[TBL] [Abstract][Full Text] [Related]
33. CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer.
Ring A; Nguyen C; Smbatyan G; Tripathy D; Yu M; Press M; Kahn M; Lang JE
Cancers (Basel); 2018 Dec; 10(12):. PubMed ID: 30572639
[No Abstract] [Full Text] [Related]
34. BECN1-knockout impairs tumor growth, migration and invasion by suppressing the cell cycle and partially suppressing the epithelial-mesenchymal transition of human triple-negative breast cancer cells.
Wu CL; Zhang SM; Lin L; Gao SS; Fu KF; Liu XD; Liu Y; Zhou LJ; Zhou PK
Int J Oncol; 2018 Sep; 53(3):1301-1312. PubMed ID: 30015871
[TBL] [Abstract][Full Text] [Related]
35. Transcription factor FOXM1 specifies chromatin DNA to extracellular vesicles.
Zhang Y; Ding N; Li Y; Ouyang M; Fu P; Peng Y; Tan Y
Autophagy; 2024 May; 20(5):1054-1071. PubMed ID: 37974331
[TBL] [Abstract][Full Text] [Related]
36. Integrated network analysis identifies hsa-miR-4756-3p as a regulator of FOXM1 in Triple Negative Breast Cancer.
Gu Y; Wang W; Wang X; Xie H; Ye X; Shu P
Sci Rep; 2019 Sep; 9(1):13830. PubMed ID: 31554904
[TBL] [Abstract][Full Text] [Related]
37. Expression of FOXM1 and related proteins in breast cancer molecular subtypes.
Lee JJ; Lee HJ; Son BH; Kim SB; Ahn JH; Ahn SD; Cho EY; Gong G
Int J Exp Pathol; 2016 Apr; 97(2):170-7. PubMed ID: 27277416
[TBL] [Abstract][Full Text] [Related]
38. Hydroxytyrosol and Oleuropein Inhibit Migration and Invasion of MDA-MB-231 Triple-Negative Breast Cancer Cell via Induction of Autophagy.
Lu HY; Zhu JS; Zhang Z; Shen WJ; Jiang S; Long YF; Wu B; Ding T; Huan F; Wang SL
Anticancer Agents Med Chem; 2019; 19(16):1983-1990. PubMed ID: 31333142
[TBL] [Abstract][Full Text] [Related]
39. Essential role for STAT3/FOXM1/ATG7 signaling-dependent autophagy in resistance to Icotinib.
Lyu X; Zeng L; Shi J; Ming Z; Li W; Liu B; Chen Y; Yuan B; Sun R; Yuan J; Zhao N; Yang X; Chen G; Yang S
J Exp Clin Cancer Res; 2022 Jun; 41(1):200. PubMed ID: 35690866
[TBL] [Abstract][Full Text] [Related]
40. Autophagy regulator BECN1 suppresses mammary tumorigenesis driven by WNT1 activation and following parity.
Cicchini M; Chakrabarti R; Kongara S; Price S; Nahar R; Lozy F; Zhong H; Vazquez A; Kang Y; Karantza V
Autophagy; 2014; 10(11):2036-52. PubMed ID: 25483966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
